Polycystic liver disease: Clinical Trials

3 trials for Polycystic liver disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated, 1 unknown. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Completed 1, Terminated 1, Unknown 1

Follow Polycystic liver disease: new trials by email Literature Review of Polycystic liver disease trials Research Report on Polycystic liver disease

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Assessment of Treatment With Laparoscopic Fenestration or Aspiration Sclerotherapy for Large Symptomatic Hepatic Cysts
aspiration sclerotherapy versus laparoscopic fenestration - Liver Cyst, Polycystic Liver Disease
Not applicableUnknownRadboud University Medical Center702022-10-012023-04-05
The Vienna RAP Pilot Study
Sirolimus - ADPKD
Not applicableCompletedMedical University of Vienna82009-11-012012-07-03
Polycystic Liver Disease in Kidney Transplant
Tacrolimus, Sirolimus, Mycophenolate Mofetil - Polycystic Liver Disease
Not applicableTerminatedMayo Clinic22009-02-012013-03-08

Narrower conditions

Polycystic Kidney, Autosomal Dominant (3)  ·  Hereditary Sensory and Autonomic Neuropathies (1)

Broader conditions

Abnormalities, Multiple (3)  ·  Ciliopathies (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Genetic Diseases, Inborn (3)  ·  Kidney Diseases (3)  ·  Kidney Diseases, Cystic (3)  ·  Male Urogenital Diseases (3)  ·  Polycystic Kidney Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Nervous System Diseases (1)

Interventions

Sirolimus (2)  ·  Mycophenolic Acid (1)  ·  Prednisone (1)  ·  Tacrolimus (1)

Sponsors

Mayo Clinic (1)  ·  Medical University of Vienna (1)  ·  Radboud University Medical Center (1)

Countries

Austria (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Gere Sunder-Plassmann, MD (1)  ·  Joost P.H. Drenth (1)  ·  Patrick Dean, M.D. (1)  ·  QI Qian, MD (1)